Needham Maintains Buy on Veracyte, Raises Price Target to $69
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $57 to $69.
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $57 to $69.